Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Raje

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|July 6, 2000
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cellsD Chauhan, P Pandey, T Hideshima, et al.
Blood Cancer Journal|January 9, 2016
Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trialN Raje, S Vadhan-Raj, W Willenbacher, et al.
British Journal of Haematology|August 24, 2006
Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cellsN Raje, S Kumar, T Hideshima, et al.
Blood|February 9, 1999
Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasoneS P Treon, J A Mollick, M Urashima, et al.
Blood|October 26, 2000
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapyT Hideshima, D Chauhan, Y Shima, et al.
Blood|July 4, 2001
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migrationK Podar, Y T Tai, F E Davies, et al.
The Journal of Bone and Joint Surgery. American Volume|June 1, 2023
Neurologic Outcomes After Radiation Therapy for Severe Spinal Cord Compression in Multiple Myeloma: A Study of 162 PatientsH Zijlstra, B M Striano, A M Crawford, et al.
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Leukemia|June 29, 2013
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKsD Cirstea, T Hideshima, L Santo, et al.
Leukemia|August 8, 2008
The research mission in myelomaP G Richardson, J San-Miguel, S Lonial, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|July 6, 2000
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cellsD Chauhan, P Pandey, T Hideshima, et al.
Blood Cancer Journal|January 9, 2016
Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trialN Raje, S Vadhan-Raj, W Willenbacher, et al.
British Journal of Haematology|August 24, 2006
Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cellsN Raje, S Kumar, T Hideshima, et al.
Blood|February 9, 1999
Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasoneS P Treon, J A Mollick, M Urashima, et al.
Blood|October 26, 2000
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapyT Hideshima, D Chauhan, Y Shima, et al.
Blood|July 4, 2001
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migrationK Podar, Y T Tai, F E Davies, et al.
The Journal of Bone and Joint Surgery. American Volume|June 1, 2023
Neurologic Outcomes After Radiation Therapy for Severe Spinal Cord Compression in Multiple Myeloma: A Study of 162 PatientsH Zijlstra, B M Striano, A M Crawford, et al.
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Leukemia|June 29, 2013
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKsD Cirstea, T Hideshima, L Santo, et al.
Leukemia|August 8, 2008
The research mission in myelomaP G Richardson, J San-Miguel, S Lonial, et al.
Pageof 6